← Back to Search

Treatment for Esophageal Cancer

N/A
Waitlist Available
Led By Ajay Bansal, MD
Research Sponsored by Midwest Biomedical Research Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-3 years
Awards & highlights

Summary

The primary purpose of this study is to test new methods to diagnose BE in time before it turns into advanced cancer. Once BE is diagnosed, the current standard of care is to monitor the disease so that complication such as cancer can be diagnosed early. The two new methods the investigators are evaluating are: a) blood test and b) brush test of the food pipe. The investigators will collect blood, bile and cells from the food pipe and stomach and measure for a biomarker called microRNA (miRNA). In the future, measurements of microRNA biomarkers could help the doctors figure out which patients are at increased risk for cancer of the esophagus.

Eligible Conditions
  • Esophageal Cancer
  • Acid Reflux
  • Barrett's Esophagus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Barrett Esophagus
Secondary outcome measures
Differences in the microRNA expression of biliary exosomes between GERD, Barrett's esophagus and Cancer

Find a Location

Who is running the clinical trial?

Midwest Biomedical Research FoundationLead Sponsor
25 Previous Clinical Trials
9,098 Total Patients Enrolled
Kansas City Veteran Affairs Medical CenterFED
23 Previous Clinical Trials
8,348 Total Patients Enrolled
University of KansasOTHER
150 Previous Clinical Trials
326,499 Total Patients Enrolled
~21 spots leftby Sep 2025